/Cooper%20Companies%2C%20Inc_%20building%20logo-by%20Sundry%20Photography%20via%20Shutterstock.jpg)
The Cooper Companies (COO), headquartered in San Ramon, California, develops, manufactures, and markets contact lens wearers. Valued at $18.6 billion by market cap, the company’s products include contact lenses for the vision care market and diagnostic products, surgical instruments, and accessories for gynecologists and obstetricians.
Companies worth $10 billion or more are generally described as “large-cap stocks,” and COO perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the medical instruments & supplies industry. COO holds a strong position in the U.S. contact lens market, driven by its diverse brand portfolio, which includes well-known names like Proclear, Biofinity, MyDay, and Clariti. Through strategic acquisitions, such as the recent purchase of a fertility company, the company continues to expand its product offerings and demonstrate financial strength. Additionally, its commitment to R&D, particularly in myopia management and contact lens technology, highlights its dedication to innovation and staying competitive in the market.
